Nov 18 (Reuters) - CVS Health ( CVS ) said on Monday it

would add four new members to its board in an agreement with

Glenview Capital Management, including the hedge fund's chief

executive Larry Robbins.

Shares of the healthcare conglomerate rose nearly 3% in

premarket trading.

Longtime investor Glenview Capital Management bought 2.8

million CVS shares during the third quarter, increasing its

stake by 31%.

"In our discussions with the leadership at Glenview, we

agreed that we can deliver greater value from our integrated

businesses to all of our stakeholders, including our customers,

consumers, colleagues and shareholders," said CVS chairman Roger

Farah.

Three other executives will join Robbins on the CVS board,

bringing the total members to 16.